Profile: Sanofi-aventis U.S. LLC. researches, develops and markets health care products. We focus on cardiovascular disease, thrombosis, oncology, diabetes, central nervous system, internal medicine & vaccines. Our ambien is indicated for the short-term treatment of insomnia. There is a low occurrence of side effects associated with the short-term use of ambien. Our allegra 180mg relieves seasonal allergy symptoms like sneezing, runny nose, itchy nose, itchy throat and watery red eyes. Our Multaq is an antiarrhythmic drug indicated to reduce the risk of cardiovascular hospitalization in patient with paroxysmal or persistent atrial fibrillation or artrial flutter, with a recent episode of AF and associated risk factors, who are in sinus rhythm or who will be cardioverted.

FDA Registration Number: 3003496686